Bringing the fundamentals into focus…
Back to Foghorn Therapeutics Inc.
How Foghorn Therapeutics Inc. stacks up
FHTX · against 1,216 other Healthcare companies
Growth
84/ 100
Near the top of its peers.
Ranked #190 of 1,217 · scores higher than 84% of peers
Bars: peers in each 10-point band of the growth score122 peers with a growth score of 80–89, including FHTX · Click a bar to see the companies
Why growth scores 84?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its revenue growth and 3-year revenue growth, which are stronger than most Healthcare peers.
- Still loss-making, but the loss per share narrowed. Earnings per share growth: — vs peer median 9.8%
- faster revenue growth over three years: stronger than 80% of peers. 3-year revenue growth: 19.1% vs peer median 5.8%
- faster revenue growth over the last year: stronger than 90% of peers. Revenue growth: 52.0% vs peer median 6.1%
Metric by metric
Position: dot = FHTX, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | FHTX | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Revenue growthHigher is better · 1,243 reported | 52.0% | 6.1% | 90% | 33% | |
| Earnings per share growthHigher is better · 682 reported | Not reported | 9.7% | — | — | 33% |
| 3-year revenue growthHigher is better · 1,192 reported | 19.1% | 5.8% | 80% | 33% |
A metric that is not reported is left out of the score; the other weights are rescaled.
Ranking by growth score
Top 5 and the companies ranked around FHTX| Rank | Company | Market cap | Growth | Overall |
|---|---|---|---|---|
| 1 | 3.1B EUR (≈$3.4B) | 100 | 100 | |
| 1 | 464M USD | 100 | 53 | |
| 3 | 8.9B HKD (≈$1.1B) | 99 | 61 | |
| 3 | 1.8B HKD (≈$224M) | 99 | 59 | |
| 3 | 7.2B TWD (≈$224M) | 99 | 41 | |
| 190 | 40.3B SEK (≈$4.0B) | 84 | 79 | |
| 190 | 1.1B USD | 84 | 50 | |
| 190 | 4.6B USD | 84 | 65 | |
| 190 | 399M USD | 84 | 32 | |
| 190 | 126M USD | 84 | 32 | |
| 190 | 1.3B CHF (≈$1.5B) | 84 | 48 | |
| 190 | 1.2B USD | 84 | 75 | |
| 190 | 10.7B USD | 84 | 65 | |
| 202 | 13.5B CNY (≈$1.9B) | 83 | 67 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score